Radiofrequency ablation of bone

Radiofrequency ablation is recommended for inclusion into benefit catalogue with restrictions for patients with metastatic spinal lesions in Austria

28

Jul 2017

The Ludwig Boltzmann Institute – Health Technology Assessment (LBI-HTA) has published results of systematic literature review of evidence in relation to efficacy and safety of radiofrequency ablation for patients with metastatic spinal lesions. In conclusion, LBI-HTA recommended radiofrequency ablation of spinal metastatic lesions for inclusion in benefit catalogue with restrictions. Read more